Pre Diagnostics AS
ASActiveOrg 912672492Lørenveien 73A, 0585 OsloResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2013 · 12 years old12 employeeshttps://pre-diagnostics.com
Loading company…
Overview
Pre Diagnostics AS is a Norwegian AS based in Oslo, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2013, the company has 12 employees and reported revenue of NOK 0 in its latest annual filing.
Revenue 2025
0M NOK
EBITDA margin
—
Net profit 2025
-6.8M NOK
+41% vs 2024
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
4.6 %
Very weakAmong the 20% lowest rated companies in the industry
20212025
Liquidity ratioCurrent assets ÷ Short-term debt
1.0×
WeakAmong the 30% lowest rated companies in the industry
20212025
Return on assets (ROA)Net profit ÷ Total assets × 100
-42.6 %
Very weakAmong the 20% lowest rated companies in the industry
20212025
EBITDA — year on year
NOK thousandsKey figures
Annual report 2025| Revenue | 0M NOK | — |
| EBITDA | -5M NOK | +47% |
| Net profit | -6.8M NOK | +41% |
| Total assets | 16.1M NOK | -16% |
| Equity | 0.7M NOK | -90% |
| Employees | 12 | — |
Company information
Legal name
PRE DIAGNOSTICS AS
Org number
912672492
Legal form
Aksjeselskap
Founded
25 October 2013 · 12 years
Share capital
NOK 220,113
Employees
12 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Daglig leder og ett styremedlem i fellesskap.
Company purpose
Utvikling og salg av diagnostiske tester samt annen virksomhet som står i forbindelse med dette.
(no translation available)
Contact
Address
Lørenveien 73A, 0585 Oslo
Website
https://pre-diagnostics.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2025), Pre Diagnostics AS reported revenue of NOK 0. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of NOK 6.8m.
At the end of 2025, equity financed 4.6% of the balance sheet, and current assets covered short-term debt 1 times.
Financials
Revenue
NOKEBITDA
NOK thousandsIncome statement
NOK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | -12,611 | -11,511 | -7,016 | -5,871 | -10,064 |
| EBITDA | -5,040 | -9,434 | -2,765 | -5,706 | -4,896 |
| Depreciation & amort. | -1,377 | -1,396 | -868 | -722 | -562 |
| EBIT | -6,417 | -10,830 | -3,633 | -6,427 | -5,458 |
| Net financials | -427 | -695 | -128 | -99 | -0 |
| Profit before tax | -6,844 | -11,525 | -3,761 | -6,526 | -5,459 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | -6,844 | -11,525 | -3,761 | -6,526 | -5,459 |
Get a credit rating – not just the numbers
Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.
Balance sheet
NOK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 16,057 | 19,064 | 15,054 | 12,054 | 8,869 |
| Equity | 742 | 7,391 | 6,940 | 4,077 | 5,851 |
| Long-term debt | 6,455 | 6,600 | 1,616 | 1,711 | 0 |
| Short-term debt | 8,860 | 5,073 | 6,498 | 6,266 | 3,017 |
| Total debt | 15,315 | 11,674 | 8,114 | 7,978 | 3,017 |
Financial ratios
5-year trendEBITDA margin
<−999 %
20212025
Equity ratio
4.6 %
Very weakAmong the 20% lowest rated companies in the industry
20212025
Return on equity
-922.8 %
Very weakAmong the 10% lowest rated companies in the industry
20212025
Net profit margin
<−999 %
20212025
Asset turnover
0.00×
Very weakAmong the 10% lowest rated companies in the industry
20212025
Debt / equity
20.65×
Very weakAmong the 10% lowest rated companies in the industry
20212025
Sector performance
24 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Return on equity (ROE)Very weak
Among the 10% lowest rated companies in the industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Very weak
Among the 20% lowest rated companies in the industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Very weak
Among the 10% lowest rated companies in the industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Very weak
Among the 20% lowest rated companies in the industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Capacity ratioWeak
Among the 40% lowest rated companies in the industry
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Gross marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Liquidity
Current ratioWeak
Among the 30% lowest rated companies in the industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioWeak
Among the 30% lowest rated companies in the industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioWeak
Among the 40% lowest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets to equityVery weak
Among the 10% lowest rated companies in the industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalVery weak
Among the 20% lowest rated companies in the industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioWeak
Among the 30% lowest rated companies in the industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Debt & solvency
Solidity ratioVery weak
Among the 20% lowest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioWeak
Among the 30% lowest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityVery weak
Among the 10% lowest rated companies in the industry
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityVery weak
Among the 10% lowest rated companies in the industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Income to debtVery weak
Among the 20% lowest rated companies in the industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtWeak
Among the 30% lowest rated companies in the industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageWeak
Among the 30% lowest rated companies in the industry
The ability to pay the interest on the company's debt out of its earnings.
Interest rate on debtWeak
Among the 30% lowest rated companies in the industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginVery weak
Among the 20% lowest rated companies in the industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Efficiency & development
Asset turnoverVery weak
Among the 10% lowest rated companies in the industry
Revenue relative to total assets — the ability to generate revenue from the asset base.
Equity to contributed capitalAverage
Around the average of companies in the same industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in equityVery weak
Among the 10% lowest rated companies in the industry
The size of this year's increase or decrease in the company's equity.
One-year change in debtWeak
Among the 30% lowest rated companies in the industry
The size of this year's increase or decrease in the company's debt.
Inventory turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
Annual reports & filings
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HS Chief Executive Officer | Chief Executive Officer | 2013 |
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
SC Board of Directors | Board of Directors | 2026 |
MS Board of Directors | Board of Directors | 2024 |
OP Chairman | Chairman | 2024 |
BN Board of Directors | Board of Directors | 2024 |
NB Board of Directors | Board of Directors | 2020 |
Former (4)
BB Board of Directors | Board of Directors | 2020 – 2024 |
TO Board of Directors | Board of Directors | 2020 – 2025 |
LC Board of Directors | Board of Directors | 2024 – 2025 |
EL Board of Directors | Board of Directors | 2021 – 2024 |
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 12.9% | 12.9% | 2025 | |
| Company | 11.62% | 11.62% | 2025 | |
| Company | 8.74% | 8.74% | 2025 | |
| Company | 6.81% | 6.81% | 2025 | |
| Individual | 6.71% | 6.71% | 2025 | |
| Company | 6.25% | 6.25% | 2025 | |
| Company | 6.19% | 6.19% | 2025 | |
| Company | 5.11% | 5.11% | 2025 | |
| Individual | 4.54% | 4.54% | 2025 | |
| Company | 4.09% | 4.09% | 2025 | |
| Company | 2.74% | 2.74% | 2025 | |
| Company | 2.63% | 2.63% | 2025 | |
| Company | 2.2% | 2.2% | 2025 | |
| Company | 1.93% | 1.93% | 2025 | |
| Company | 1.59% | 1.59% | 2025 | |
| Individual | 1.59% | 1.59% | 2025 | |
| Company | 1.14% | 1.14% | 2025 | |
| Individual | 1.14% | 1.14% | 2025 | |
| Individual | 0.94% | 0.94% | 2025 | |
| Company | 0.84% | 0.84% | 2025 | |
| Individual | 0.23% | 0.23% | 2025 | |
| Individual | 1.99% | 1.99% | 2023 | |
Bioventix Plc | Company | 5.25% | 5.25% | 2024 |
Jekl Holdings Pty Ltd Atf | Company | 3.3% | 3.3% | 2023 |
Francis Joseph Swenson | Company | 2.81% | 2.81% | 2024 |
Jekl Holdings Pty Ltd Atf The Ki | Company | 2.71% | 2.71% | 2024 |
| Company | 1.08% | 1.08% | 2023 |
One in three Danish companies experiences fraud
Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.
Related companies
Company hierarchy
Bioventix Plc5.111%Nistad Pd As6.8147%Hathon Holding As8.741%Canio As6.2468%Orinoco As12.9025%Inven2 As11.6152%Landerud Holding As4.09%Norsemeter As2.2%Rolfs Holding As1.59%Giercksky+Nilssen As1.14%Lakeside As0.84%Jekl Holdings Pty Ltd Atf3.3%Ocean Projects As1.08%
Pre Diagnostics AS (this company)Pre Vention As81.25% ownedPre Neurolab AS100% ownedBoard network connections
Board members of Pre Diagnostics AS also hold positions in 91 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Birgit Nistad | Board of Directors | 45 companiesMany roles |
| Nicolas Brun-Lie | Board of Directors | 15 companiesMany roles |
| Håkon Sæterøy | Chief Executive Officer | 9 companiesMany roles |
| Thorbjørn Overholt | Board of Directors | 9 companiesMany roles |
| Emilie Lasson | Board of Directors | 5 companies |
| Ståle Charles Kvitle | Board of Directors | 4 companies |
| Marie Skarbøvik Buchmann | Board of Directors | 2 companies |
| Ole Petter Ottersen | Chairman | 2 companies |
Frequently asked questions
What is the Org number of Pre Diagnostics AS?
Pre Diagnostics AS is registered with Brønnøysundsregistrene under Org 912672492.
How many employees does Pre Diagnostics AS have?
Pre Diagnostics AS employs 12 people as of the latest annual report.
Who is the CEO of Pre Diagnostics AS?
Håkon Sæterøy is the CEO of Pre Diagnostics AS.
Who is the chairman of Pre Diagnostics AS?
Ole Petter Ottersen chairs the board of Pre Diagnostics AS, in role since 2024.
Where is Pre Diagnostics AS headquartered?
Pre Diagnostics AS's registered address is Lørenveien 73A.